1-4 of 4
Alice Long
Close
Sort by
Journal Articles

Poor Clinical Outcome in Pediatric Immunotherapy Is Mediated By a Pre-Existing Overactive IL-18-IFNy Immune Phenotype

Katelyn Burleigh, Anna Kus, Alice Long, Michael C. Jensen, Seth Masters, James E Vince, Bobbie-Jo Webb-Robertson, Rebecca A Gardner, Heather Gustafson
Journal: Blood
Blood (2021) 138 (Supplement 1): 168.
https://doi.org/10.1182/blood-2021-148013
Published: 2021
Journal Articles

Restoring a Normal T Cell Receptor Repertoire Using the Xcellerate™ Technology: A Potential Therapeutic Strategy for Patients with Hematological Disorders and Autoimmune Diseases.

Alice Long, PhD, Jahan Khalili, Joy Lawrence, Ronald J. Berenson, MD, Mark L. Bonyhadi, PhD
Journal: Blood
Blood (2004) 104 (11): 3853.
https://doi.org/10.1182/blood.V104.11.3853.3853
Published: 2004
Journal Articles

Activated and Expanded T Cells for Potential Therapy of Patients with Autoimmune Diseases.

Alice Long, PhD, Mark Bonyhadi, PhD, Christophe Ferrand, PhD, Mark Frohlich, MD, Ronald J. Berenson, MD
Journal: Blood
Blood (2004) 104 (11): 3854.
https://doi.org/10.1182/blood.V104.11.3854.3854
Published: 2004
Journal Articles

Biological Characteristics of T Cells from CD4 Idiopathic Lymphocytopenia Patients Activated and Expanded Using Xcellerate™ Technology.

Joy Lawrence, Mark L. Bonyhadi, PhD, Charlotte Cunningham-Rundles, MDPhD, Ronald J. Berenson, MD, Alice Long, PhD
Journal: Blood
Blood (2004) 104 (11): 3834.
https://doi.org/10.1182/blood.V104.11.3834.3834
Published: 2004